Pasar al contenido principal

DESARROLLO DE FORMULAS ALIMENTARIAS DE PRECISION DIRIGIDAS AL TRATAMIENTO DEL CANCER DE COLON: DISEÑO Y VALIDACION

PID2019-110183RB-C21

•
Nombre agencia financiadora Agencia Estatal de Investigación
Acrónimo agencia financiadora AEI
Programa Programa Estatal de I+D+i Orientado a los Retos de la Sociedad
Convocatoria Proyectos de I+D+i (Generación de Conocimiento y Retos Investigación)
Año convocatoria 2019
Plan Estatal 2017-2020 Plan Estatal de Investigación Científica y Técnica y de Innovación
Centro beneficiario FUNDACION IMDEA NUTRICIÓN

Resultados relacionados

Resultados totales (Incluyendo duplicados): 15
Encontrada(s) 1 página(s)

Repositorio Digital de la UPF
Publicación Artículo científico (JournalArticle)

Fatty acids homeostasis during fasting predicts protection from chemotherapy toxicity

  • Barradas, Marta
  • Lázaro, Iolanda
  • Pozo Mendoza, Óscar J., 1975-
  • Sala Vila, Aleix
  • Fernandez-Marcos, Pablo J.
Fasting exerts beneficial effects in mice and humans, including protection from chemotherapy toxicity. To explore the involved mechanisms, we collect blood from humans and mice before and after 36 or 24 hours of fasting, respectively, and measure lipid composition of erythrocyte membranes, circulating micro RNAs (miRNAs), and RNA expression at peripheral blood mononuclear cells (PBMCs). Fasting coordinately affects the proportion of polyunsaturated versus saturated and monounsaturated fatty acids at the erythrocyte membrane; and reduces the expression of insulin signaling-related genes in PBMCs. When fasted for 24 hours before and 24 hours after administration of oxaliplatin or doxorubicin, mice show a strong protection from toxicity in several tissues. Erythrocyte membrane lipids and PBMC gene expression define two separate groups of individuals that accurately predict a differential protection from chemotherapy toxicity, with important clinical implications. Our results reveal a mechanism of fasting associated with lipid homeostasis, and provide biomarkers of fasting to predict fasting-mediated protection from chemotherapy toxicity., Work at the laboratory of P.J.F.M. is funded by the Ramón Areces Foundation, (CIVP18A3891), Asociación Española contra el Cáncer-AECC (SIRTBIO—LABAE18008FERN), a Ramon y Cajal Award from the Spanish Ministry of Science, Innovation and Universities (MICINN) (RYC-2017-22335), RETOS projects Program of MICINN (SAF2017-85766-R) and the Portuguese Foundation for Science and Technology (FCT-MCTES, SFRH/BD/124022/2016). Work at the laboratory of ARM was funded by the MICINN (PID2019-110183RB-C21), Regional Government of Community of Madrid (P2018/BAA-4343-ALIBIRD2020-CM) and the Ramón Areces Foundation. Work at the laboratory of A.D.R. Funded by the Comunidad de Madrid—Talento Grant 2018-T1/BMD-11966 and the MICINN PID-2019-106893RA-100. Work at the laboratory of L.D. is funded by projects from the Health Research Fund (ISCIII FIS PI14/01374 and FISPI17/00508) and from a Manuel de Oya research fellowship from the Beer and Health Foundation. Work at the laboratory of A.E. is funded by a Ramon y Cajal Award from MICINN (RYC-2013-13546) and RETOS projects Program of the MICINN, co-funded by the European Regional Development Fund (ERDF) (SAF2015-67538-R). Work in the laboratory of M.S. was funded by the IRB and by grants from the Spanish Ministry of Economy co-funded by the European Regional Development Fund (ERDF) (SAF2013-48256-R), the European Research Council (ERC-2014-AdG/669622), and the “laCaixa” Foundation.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Intestinal Intervention Strategy Targeting Myeloid Cells to Improve Hepatic Immunity during Hepatocarcinoma Development

  • Bouzas Muñoz, Adrián
  • Giménez-Bastida, J. A.
  • Tejedor, Aurora García
  • Haros, Monika
  • Gómez de Cedrón, Marta
  • Ramírez de Molina, Ana
  • Laparra, José Moisés
Innate immunity in the tumor microenvironment plays a pivotal role in hepatocarcinoma (HCC) progression. Plant seeds provide serine-type protease inhibitors (SETIs), which can have a significant influence on liver inflammation and macrophage function. To elucidate the influence of SETIs to counter pro-tumorigenic conditions, at the early stages of HCC development, it was used as an established model of diethylnitrosamine/thioacetamide-injured liver fed with a standard diet (STD) or high-fat diet (42%) (HFD). The administration of SETIs improved survival and ameliorated tumor burden via modulation of monocyte-derived macrophages as key effectors involved in diet-induced HCC development. RT-qPCR analyses of hepatic tissue evidenced a diet-independent downregulatory effect of SETIs on the transcripts of CD36, FASN, ALOX15, and SREBP1c; however, animals fed with an STD showed opposing effects for PPAR and NRLP3 levels. These effects were accompanied by a decreased production of IL-6 and IL-17 but increased that of TNF in animals receiving SETIs. Moreover, only animals fed an HFD displayed increased concentrations of the stem cell factor. Overall, SETIs administration decreased the hepatic contents of lysophosphatydilcholine, phosphatidylinositol, phosphatidylcholine, and phosphatidyl ethanolamine. Notably, animals that received SETIs exhibited increased hepatic proportions of CD68+CX3CR1+CD74+ cells and at a higher rate in those animals fed an HFD. Altogether, the data evidence that oral administration of SETIs modulates the tumor microenvironment, improving hepatic innate immune response(s) and favoring a better antitumoral environment. It represents a path forward in developing coadjutant strategies to pharmacological therapies, with either a preventive or therapeutic character, to counter physiopathological conditions at early stages of HCC development., This work was financially supported by grants Food4ImNut (PRP_PID-2019-107650RBC22, Ministry of Science, Innovation and Universities—MICIU) and CYTED (La ValSe-Food, 119RT0S67); by Ministerio de Ciencia e Innovación, Spain (PID2019-110183RB-C21); and by Ramon Areces Foundation (CIVP19A5937). A.B. has a predoctoral grant from the industrial predoctoral program of Community of Madrid (IND2017/BIO-7857). J.A.G.-B. was supported by a Standard European Marie Curie Fellowship from the European Commission (Grant Agreement 838991)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Evolution of a histone variant involved in compartmental regulation of NAD metabolism

  • Guberovic, Iva
  • Hurtado-Bagès, Sarah
  • Rivera-Casas, Ciro
  • Knobloch, Gunnar
  • Malinverni, Roberto
  • Valero, Vanesa
  • Leger, Michelle M.
  • García, Jesús
  • Basquin, Jerome
  • Gómez de Cedrón, Marta
  • Frigolé-Vivas, Marta
  • Cheema, Manjinder S.
  • Pérez, Ainhoa
  • Ausió, Juan
  • Ramírez de Molina, Ana
  • Salvatella, Xavier
  • Ruiz-Trillo, Iñaki
  • Eirín-López, José María
  • Ladurner, Andreas G.
  • Buschbeck, Marcus
NAD metabolism is essential for all forms of life. Compartmental regulation of NAD consumption, especially between the nucleus and the mitochondria, is required for energy homeostasis. However, how compartmental regulation evolved remains unclear. In the present study, we investigated the evolution of the macrodomain-containing histone variant macroH2A1.1, an integral chromatin component that limits nuclear NAD consumption by inhibiting poly(ADP-ribose) polymerase 1 in vertebrate cells. We found that macroH2A originated in premetazoan protists. The crystal structure of the macroH2A macrodomain from the protist Capsaspora owczarzaki allowed us to identify highly conserved principles of ligand binding and pinpoint key residue substitutions, selected for during the evolution of the vertebrate stem lineage. Metabolic characterization of the Capsaspora lifecycle suggested that the metabolic function of macroH2A was associated with nonproliferative stages. Taken together, we provide insight into the evolution of a chromatin element involved in compartmental NAD regulation, relevant for understanding its metabolism and potential therapeutic applications., For technical support, we thank the research service facilities of IJC and IGTP, the Crystallization Facility of the Max Planck Institute of Biochemistry, the ICTS NMR facility from the Scientific and Technological Centres of the University of Barcelona and Biophysics Core Facility of BMC-LMU. I.G. was a fellow of the Marie Skłodowska Curie Training network ‘ChroMe’ (H2020-MSCA-ITN-2015-675610, awarded to M.B. and A.G.L.). The project was further supported by national grants (nos. RTI2018-094005-B-I00 and BFU2015-66559-P from FEDER/Ministerio de Ciencia e Innovación—Agencia Estatal de Investigación to M.B.). Research in the participating labs was further supported by the following grants: the Marie Skłodowska Curie Training network ‘INTERCEPT-MDS’ no. H2020-MSCA-ITN-2020-953407 (to M.B.), MINECO-ISCIII no. PIE16/00011 (to M.B.); the Deutsche José Carreras Leukämie Stiftung DJCLS (no. 14R/2018 to M.B.), AGAUR (no. 2017-SGR-305 to M.B.), Fundació La Marató de TV3 (no. 257/C/2019 to M.B.), German Research Foundation Project (ID 213249687—SFB 1064 and Project ID 325871075—SFB 1309 to A.G.L.), the Spanish Ministry of Science (PID2019-110183RB-C21 to A.R.M.), Community of Madrid (P2018/BAA-4343-ALIBIRD2020-CM to A.R.M), Ramón Areces Foundation (to A.R.M.), National Science Foundation (EF-1921402 to J.M.E.L.), 2015 International Doctoral Fellowship La Caixa-Severo Ochoa (to M.F.V.), Marie Skłodowska-Curie Individual Fellowship (no. 747789 to M.M.L.), Juan de la Cierva-Incorporación (IJC2018-036657-I to M.M.L., ERC-2012-CoG-616960 to I.R.T.), MINECO (BFU2017-90114-P to I.R.T.), AGAUR (2017-SGR-324 to X.S.) and MINECO (BIO2015-70092-R and ERC-2014-CoG-648201 to X.S.). Research at the IJC is supported by the ‘La Caixa’ Foundation, Fundació Internacional Josep Carreras, Celgene Spain and the CERCA Programme/Generalitat de Catalunya.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Genetic data from the extinct giant rat from Tenerife (Canary Islands) points to a recent divergence from mainland relatives

  • Renom, P.
  • Dios Martínez, Antonio de
  • Civit, Sergi
  • Llovera, Laia
  • Sánchez-Gracia, Alejandro
  • Lizano, Esther
  • Rando, Juan Carlos
  • Marqués-Bonet, Tomàs
  • Kergoat, Gael J.
  • Casanovas-Vilar, Isaac
  • Lalueza-Fox, Carles
Evolution of vertebrate endemics in oceanic islands follows a predictable pattern, known as the island rule, according to which gigantism arises in originally small-sized species and dwarfism in large ones. Species of extinct insular giant rodents are known from all over the world. In the Canary Islands, two examples of giant rats, †Canariomys bravoi and †Canariomys tamarani, endemic to Tenerife and Gran Canaria, respectively, disappeared soon after human settlement. The highly derived morphological features of these insular endemic rodents hamper the reconstruction of their evolutionary histories. We have retrieved partial nuclear and mitochondrial data from †C. bravoi and used this information to explore its evolutionary affinities. The resulting dated phylogeny confidently places †C. bravoi within the African grass rat clade (Arvicanthis niloticus). The estimated divergence time, 650 000 years ago (95% higher posterior densities: 373 000-944 000), points toward an island colonization during the Günz-Mindel interglacial stage. †Canariomys bravoi ancestors would have reached the island via passive rafting and then underwent a yearly increase of mean body mass calculated between 0.0015 g and 0.0023 g; this corresponds to fast evolutionary rates (in darwins (d), ranging from 7.09 d to 2.78 d) that are well above those observed for non-insular mammals., For technical support, we thank the research service facilities of IJC and IGTP, the Crystallization Facility of the Max Planck Institute of Biochemistry, the ICTS NMR facility from the Scientific and Technological Centres of the University of Barcelona and Biophysics Core Facility of BMC-LMU. I.G. was a fellow of the Marie Skłodowska Curie Training network ‘ChroMe’ (H2020-MSCA-ITN-2015-675610, awarded to M.B. and A.G.L.). The project was further supported by national grants (nos. RTI2018-094005-B-I00 and BFU2015-66559-P from FEDER/Ministerio de Ciencia e Innovación—Agencia Estatal de Investigación to M.B.). Research in the participating labs was further supported by the following grants: the Marie Skłodowska Curie Training network ‘INTERCEPT-MDS’ no. H2020-MSCA-ITN-2020-953407 (to M.B.), MINECO-ISCIII no. PIE16/00011 (to M.B.); the Deutsche José Carreras Leukämie Stiftung DJCLS (no. 14R/2018 to M.B.), AGAUR (no. 2017-SGR-305 to M.B.), Fundació La Marató de TV3 (no. 257/C/2019 to M.B.), German Research Foundation Project (ID 213249687—SFB 1064 and Project ID 325871075—SFB 1309 to A.G.L.), the Spanish Ministry of Science (PID2019-110183RB-C21 to A.R.M.), Community of Madrid (P2018/BAA-4343-ALIBIRD2020-CM to A.R.M), Ramón Areces Foundation (to A.R.M.), National Science Foundation (EF-1921402 to J.M.E.L.), 2015 International Doctoral Fellowship La Caixa-Severo Ochoa (to M.F.V.), Marie Skłodowska-Curie Individual Fellowship (no. 747789 to M.M.L.), Juan de la Cierva-Incorporación (IJC2018-036657-I to M.M.L., ERC-2012-CoG-616960 to I.R.T.), MINECO (BFU2017-90114-P to I.R.T.), AGAUR (2017-SGR-324 to X.S.) and MINECO (BIO2015-70092-R and ERC-2014-CoG-648201 to X.S.). Research at the IJC is supported by the ‘La Caixa’ Foundation, Fundació Internacional Josep Carreras, Celgene Spain and the CERCA Programme/Generalitat de Catalunya.
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

The chemokine receptor CCR5 links memory CD4+ T cell metabolism to T Cell antigen receptor nanoclustering

  • Blanco, Raquel
  • Gómez de Cedrón, Marta
  • Gámez-Reche, Laura
  • Martín-Leal, Ana
  • González-Martín, Alicia
  • Lacalle, Rosa Ana
  • Ramirez, Ana
  • Mañes, Santos
© 2021 Blanco, Gómez de Cedrón, Gámez-Reche, Martín-Leal, González-Martín, Lacalle, Ramírez de Molina and Mañes., The inhibition of anabolic pathways, such as aerobic glycolysis, is a metabolic cornerstone of memory T cell differentiation and function. However, the signals that hamper these anabolic pathways are not completely known. Recent evidence pinpoints the chemokine receptor CCR5 as an important player in CD4+ T cell memory responses by regulating T cell antigen receptor (TCR) nanoclustering in an antigen-independent manner. This paper reports that CCR5 specifically restrains aerobic glycolysis in memory-like CD4+ T cells, but not in effector CD4+ T cells. CCR5-deficient memory CD4+ T cells thus show an abnormally high glycolytic/oxidative metabolism ratio. No CCR5-dependent change in glucose uptake nor in the expression of the main glucose transporters was detected in any of the examined cell types, although CCR5-deficient memory cells did show increased expression of the hexokinase 2 and pyruvate kinase M2 isoforms, plus the concomitant downregulation of Bcl-6, a transcriptional repressor of these key glycolytic enzymes. Further, the TCR nanoclustering defects observed in CCR5-deficient antigen-experienced CD4+ T cells were partially reversed by incubation with 2-deoxyglucose (2-DG), suggesting a link between inhibition of the glycolytic pathway and TCR nanoscopic organization. Indeed, the treatment of CCR5-deficient lymphoblasts with 2-DG enhanced IL-2 production after antigen re-stimulation. These results identify CCR5 as an important regulator of the metabolic fitness of memory CD4+ T cells, and reveal an unexpected link between T cell metabolism and TCR organization with potential influence on the response of memory T cells upon antigen re-encounter., This research was funded by the Spanish Ministerio de Economía y Competitividad (SAF2017–83732-R to SM), the projects PID2020-116303RB-I00/MCIN/AEI/10.13039/501100011033 (to SM) and PID2019-110183RB-C21/MCIN/AEI/10.13039/501100011033 (to AR), the Comunidad de Madrid (B2017/BMD-3733/IMMUNOTHERCAN-CM to SM; P2018/BAA-4343-ALIBIRD2020-CM to AR), and the Merck-Salud Foundation (to SM). AM-L was a recipient of the Formación del Personal Universitario predoctoral fellowship from the Spanish Ministry of Education (FPU13/04430)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Potential protective effect against SARS-CoV-2 infection by APOE rs7412 polymorphism

  • Espinosa-Salinas, Isabel
  • Colmenarejo, Gonzalo
  • Fernández-Díaz, Cristina M.
  • Gómez de Cedrón, Marta
  • Martínez, J. Alfredo
  • Reglero, Guillermo
  • Ramírez de Molina, Ana
The pandemic burden caused by the SARS-CoV-2 coronavirus constitutes a global public health emergency. Increasing understanding about predisposing factors to infection and severity is now a priority. Genetic, metabolic, and environmental factors can play a crucial role in the course and clinical outcome of COVID-19. We aimed to investigate the putative relationship between genetic factors associated to obesity, metabolism and lifestyle, and the presence and severity of SARS-CoV-2 infection. A total of 249 volunteers (178 women and 71 men, with mean and ± SD age of 49 ± 11 years) characterized for dietary, lifestyle habits and anthropometry, were studied for presence and severity of COVID-19 infection, and genotyped for 26 genetic variants related to obesity, lipid profile, inflammation, and biorhythm patterns. A statistically significant association was found concerning a protective effect of APOE rs7412 against SARS-CoV-2 infection (p = 0.039; OR 0.216; CI 0.084, 0.557) after correction for multiple comparisons. This protective effect was also ascribed to the APOɛ2 allele (p = 0.001; OR 0.207; CI 0.0796, 0.538). The genetic variant rs7412 resulting in ApoE2, genetic determinant of lipid and lipoprotein levels, could play a significant role protecting against SARS-CoV-2 infection., The authors want to express their gratitude to the GENYAL Platform of Clinical Trials in Nutrition and Health of IMDEA Food Institute for their support, as well as the Counceling of Education of the Community of Madrid for their support in the constitution of GENYAL, and all the volunteers participating in this study. This research was funded by the Plan Nacional I + D + i PID2019 ‐110183RB ‐C21, FACINGLCOVID-CM project. Funding REACT EU Program (Comunidad de Madrid and The European Regional Development Fund. ERDF. European Union). Regional Government of Community of Madrid (Y2020/BIO-6350). Genomic Laboratory GENYALLab (REDLAB, the laboratories network of the Community of Madrid, under the registration number 440). GENYAL LAB participates in ALIBIRD2020-CM project (S2018/BAA-4343): "Therapeutic formulas of precision nutrition for cancer", supported by program call of R & D Activities among Research Groups of the Community of Madrid (Technologies 2018) and co-financed with European Union Structural Funds., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Pomegranate extract augments energy expenditure counteracting the metabolic stress associated with high-fat-diet-induced obesity

  • Reguero, Marina
  • Gómez de Cedrón, Marta
  • Sierra-Ramírez, Aranzazu
  • Fernández-Marcos, Pablo José
  • Reglero, Guillermo
  • Quintela, José Carlos
  • Ramírez de Molina, Ana
This article belongs to the Special Issue Natural Products and Obesity., Obesity is associated to a low grade of chronic inflammation leading to metabolic stress, insulin resistance, metabolic syndrome, dislipidemia, cardiovascular disease, and even cancer. A Mediterranean diet has been shown to reduce systemic inflammatory factors, insulin resistance, and metabolic syndrome. In this scenario, precision nutrition may provide complementary approaches to target the metabolic alterations associated to “unhealthy obesity”. In a previous work, we described a pomegranate extract (PomE) rich in punicalagines to augment markers of browning and thermogenesis in human differentiated adipocytes and to augment the oxidative respiratory capacity in human differentiated myocytes. Herein, we have conducted a preclinical study of high-fat-diet (HFD)-induced obesity where PomE augments the systemic energy expenditure (EE) contributing to a reduction in the low grade of chronic inflammation and insulin resistance associated to obesity. At the molecular level, PomE promotes browning and thermogenesis in adipose tissue, reducing inflammatory markers and augmenting the reductive potential to control the oxidative stress associated to the HFD. PomE merits further investigation as a complementary approach to alleviate obesity, reducing the low grade of chronic inflammation and metabolic stress., This research was funded by the Regional Government of Community of Madrid IND2017/BIO-7826; P2018/BAA-4343-ALIBIRD2020-CM), Ministerio de Ciencia e Innovación, Spain (PID2019-110183RB-C21); Ramon Areces Foundation (CIVP19A5937); EU Structural Funds and COST Action (CA17118); Synergistic Projects Community of Madrid (NUTRISION-CM/Y2020/BIO-6350); and REACT EU Program (Comunidad de Madrid and The European Regional Development Fund. ERDF. European Union-FACINGLCOVID-CM project)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Phenolic diterpenes from Rosemary supercritical extract inhibit non-small cell lung cancer lipid metabolism and synergise with therapeutic drugs in the clinic

  • Bouzas, Adrián
  • Gómez de Cedrón, Marta
  • Colmenarejo, Gonzalo
  • Laparra, José Moisés
  • Moreno-Rubio, Juan
  • Montoya, Juan Jose
  • Reglero, Guillermo
  • Casado, Enrique
  • Tabarés, Beatriz
  • Sereno, María
  • Ramírez de Molina, Ana
Lung cancer is one of the most deadly and common cancers in the world. The molecular features of patient’s tumours dictate the different therapeutic decisions, which combines targeted therapy, chemotherapy, and immunotherapy. Altered cellular metabolism is one of the hallmarks of cancer. Tumour cells reprogram their metabolism to adapt to their novel requirements of growth, proliferation, and survival. Together with the Warburg effect, the role of lipid metabolism alterations in cancer development and prognosis has been highlighted. Several lipid related genes have been shown to promote transformation and progression of cancer cells and have been proposed as biomarkers for prognosis. Nevertheless, the exact mechanisms of the regulation of lipid metabolism and the biological consequences in non-small cell lung cancer (NSCLC) have not been elucidated yet. There is an urgent necessity to develop multidisciplinary and complementary strategies to improve NSCLC patients´ well-being and treatment response. Nutrients can directly affect fundamental cellular processes and some diet-derived ingredients, bioactive natural compounds and natural extracts have been shown to inhibit the tumour growth in preclinical and clinical trials. Previously, we described a supercritical extract of rosemary (SFRE) (12 - 16% composition of phenolic diterpenes carnosic acid and carnosol) as a potential antitumoral agent in colon and breast cancer due to its effects on the inhibition of lipid metabolism and DNA synthesis, and in the reduction of resistance to 5-FluoroUracil (5-FU). Herein, we demonstrate SFRE inhibits NSCLC cell bioenergetics identifying several lipid metabolism implicated targets. Moreover, SFRE synergises with standard therapeutic drugs used in the clinic, such as cisplatin, pemetrexed and pembrolizumab to inhibit of cell viability of NSCLC cells. Importantly, the clinical relevance of SFRE as a complement in the treatment of NSCLC patients is suggested based on the results of a pilot clinical trial where SFRE formulated with bioactive lipids (PCT/ES2017/070263) diminishes metabolic and inflammatory targets in peripheral-blood mononuclear cells (PBMC), such as MAPK (p=0.04), NLRP3 (p=0.044), and SREBF1 (p=0.047), which may augment the immune antitumour function. Based on these results, SFRE merits further investigation as a co-adjuvant in the treatment of NSCLC., This research was funded by Regional Government of Community of Madrid (IND2017/BIO-7857; P2018/BAA-4343-ALIBIRD2020-CM), Ministerio de Ciencia e Innovación, Spain (PID2019-110183RB-C21); Ramon Areces Foundation (CIVP19A5937); EU Structural Funds and COST Action (CA17118); Synergistic Projects Community of Madrid (NUTRISION-CM/Y2020/BIO-6350) and REACT EU Program (Comunidad de Madrid and The European Regional Development Fund. ERDF. European Union- FACINGLCOVID-CM project). Adrián Bouzas has a predoctoral grant from the industrial predoctoral program of Community of Madrid (IND2017/BIO-7857)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Biological activities of miracle berry supercritical extracts as metabolic regulators in chronic diseases

  • Wagner, Sonia
  • Gómez de Cedrón, Marta
  • Navarro del Hierro, Joaquín
  • Martín Hernández, Diego
  • Siles-Sánchez, María de las Nieves
  • Santoyo, Susana
  • Jaime, Laura
  • Martín, Diana
  • Fornari, Tiziana
  • Ramírez de Molina, Ana
This article belongs to the Special Issue Cancer Metabolism: Molecular Targeting and Implications for Therapy., Synsepalum dulcificum (Richardella dulcifica) is a berry fruit from West Africa with the ability to convert the sour taste into a sweet taste, and for this reason, the fruit is also known as the “miracle berry” (MB). The red and bright berry is rich in terpenoids. The fruit’s pulp and skin contain mainly phenolic compounds and flavonoids, which correlate with their antioxidant activity. Different polar extracts have been described to inhibit cell proliferation and transformation of cancer cell lines in vitro. In addition, MB has been shown to ameliorate insulin resistance in a preclinical model of diabetes induced by a chow diet enriched in fructose. Herein, we have compared the biological activities of three supercritical extracts obtained from the seed—a subproduct of the fruit—and one supercritical extract obtained from the pulp and the skin of MB. The four extracts have been characterized in terms of total polyphenols content. Moreover, the antioxidant, anti-inflammatory, hypo-lipidemic, and inhibition of colorectal cancer cell bioenergetics have been compared. Non-polar supercritical extracts from the seed are the ones with the highest effects on the inhibition of bioenergetic of colorectal (CRC) cancer cells. At the molecular level, the effects on cell bioenergetics seems to be related to the inhibition of main drivers of the de novo lipogenesis, such as the sterol regulatory element binding transcription factor (SREBF1) and downstream molecular targets fatty acid synthase (FASN) and stearoyl coenzyme desaturase 1 (SCD1). As metabolic reprograming is considered as one of the hallmarks of cancer, natural extracts from plants may provide complementary approaches in the treatment of cancer. Herein, for the first time, supercritical extracts from MB have been obtained, where the seed, a by-product of the fruit, seems to be rich in antitumor bioactive compounds. Based on these results, supercritical extracts from the seed merit further research to be proposed as co-adjuvants in the treatment of cancer., This research was funded by Regional Government of Community of Madrid (IND2018/BIO-10097; P2018/BAA-4343-ALIBIRD2020-CM), Ministerio de Ciencia e Innovación, Spain (PID2019-110183RB-C21); Spanish Government (Project: PID2019-110183RB-C22/AEI/10.13039/501100011033); Ramon Areces Foundation (CIVP19A5937); EU Structural Funds and COST Action (CA17118); Synergistic Projects Community of Madrid (NUTRISION-CM/Y2020/BIO-6350), and REACT EU Program (Comunidad de Madrid and The European Regional Development Fund). Sonia Wagner has a predoctoral grant from the industrial predoctoral program of Community of Madrid (IND2018/BIO-10097)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

NOX2 and NOX4 control mitochondrial function in chronic myeloid leukaemia

  • Romo-González, Marta
  • Ijurko, Carla
  • Alonso, María Teresa
  • Gómez de Cedrón, Marta
  • Ramirez, Ana
  • Soriano, María Eugenia
  • Hernández-Hernández, Ángel
Cancer cells are characterised by an elevated metabolic plasticity and enhanced production of reactive oxygen species (ROS), two features acknowledged as hallmarks in cancer, with a high translational potential to the therapeutic setting. These aspects, that have been traditionally studied separately, are in fact intimately intermingled. As part of their transforming activity, some oncogenes stimulate rewiring of metabolic processes, whilst simultaneously promoting increased production of intracellular ROS. In this scenario the latest discoveries suggest the relevance of nicotinamide adenine dinucleotide phosphate (NADPH) oxidases (NOX) to connect ROS production and metabolic control. Here we have analysed the relevance of NOX2 and NOX4 in the regulation of metabolism in chronic myeloid leukaemia (CML), a neoplasia driven by the expression of the breakpoint cluster region-Abelson fusion oncogene (BCR-ABL). Silencing of NOX2 enhances glycolysis and oxidative phosphorylation rates, together with an enhanced production of mitochondrial ROS and a decrease in mitochondrial DNA copy number, which reflects mitochondrial dysfunction. NOX4 expression was upregulated upon NOX2 silencing, and this was required to alter mitochondrial function. Our results support the relevance of NOX2 to regulate metabolism-related signalling pathways downstream of BCR-ABL. Overall we show that NOX2, through the regulation of NOX4 expression, controls metabolism and mitochondrial function in CML cells. This notion was confirmed by transcriptomic analyses, that strongly relate both NOX isoforms with metabolism regulation in CML., Marta Romo-González and Carla Ijurko were recipient of pre-doctoral fellowships from the Regional Government of Castile and Leon, Spain and ERDF funds. Funding sources were as follows: Angel Hernández-Hernández lab: Spanish Government (PID2020-117692RB-I00), Regional Government of Castile & Leon (SA077P20) and Ramón Areces Foundation (CIV17A2822). Ana Ramirez de Molina lab: Spanish Government (PID2019-110183RB-C21), Regional Government of Community of Madrid (P2018/BAA-4343-ALIBIRD2020-CM), Synergistic Projects Community of Madrid NUTRISION-CM/Y2020/BIO-6350. Maria Teresa Alonso lab: Spanish Government (PID2020-116086RB-I00)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Novel bioactive extract from yarrow obtained by the supercritical antisolvent-assisted technique inhibits lipid metabolism in colorectal cancer

  • Gómez de Cedrón, Marta
  • Siles-Sánchez, María de las Nieves
  • Martín Hernández, Diego
  • Jaime, Laura
  • Santoyo, Susana
  • Ramírez de Molina, Ana
[Background]: Altered lipid metabolism in cancer is associated to dissemination and prognosis. Bioactive compounds naturally occurring in Achillea millefolium L. (yarrow) have been reported to exert antitumour activities. Food biotechnology may provide on-demand mixtures of bioactive compounds with complementary activities in cancer treatment., [Methods]: Supercritical-antisolvent-precipitation (SAS) has been applied to fractionate the bioactive compounds from an Ultrasound-Assisted-Extraction yarrow extract resulting in two extracts with distinct polarity, yarrow-precipitate-(PP) and yarrow-separator-(Sep). Total phenolic content and relevant essential oils have been characterized. Antioxidant, anti-inflammatory and antiproliferative activities have been compared. Moreover, the effect on the inhibition of colorectal cancer cells’ bioenergetics has been evaluated., [Results]: Yarrow-PP exerted the highest antioxidant activity, even higher than the complete UAE-yarrow extract, meanwhile yarrow-Sep showed the highest anti-inflammatory activity, even higher than the complete UAE-yarrow extract. Interestingly, yarrow-Sep inhibited key lipid metabolic targets in CRC cells extensively shown to be implicated in cancer dissemination and prognosis —SREBF1, FASN, ABCA1 and HMGCR— and epithelial to mesenchymal targets—CDH1, ATP1B1, CDH2 and Vimentin—augmenting cell adhesion., [Conclusions]: In summary, SAS technology has been applied to provide a novel combination of bioactive compounds, yarrow-Sep, which merits further research to be proposed as a potential complementary nutraceutical in the treatment of CRC., The authors declare that financial support was received for the research, authorship, and/or publication of this article. SS and LJ: Ministerio de Ciencia e Innovación, Spain (PID2019-110183RB-C22/MCIN/AEI/10.13039/501100011033); AR: the Regional Government of Community of Madrid (P2018/BAA-4343-ALIBIRD2020-CM), Ministerio de Ciencia e Innovación, Spain (PID 2019-110183RB-C21/MCIN/AEI/10.13039/501100011033), Ramon Areces Foundation (CIVP19A5937), EU Structural Funds and COST Action (CA17118), Synergistic Projects Community of Madrid (NUTRISION-CM/Y2020/BIO-6350), and REACT EU Program (Comunidad de Madrid and the European Regional Development Fund. ERDF. European Union- FACINGLCOVID-CM project). The authors thank Universidad Autónoma de Madrid for the grant “Formacion de personal Investigador FPI-UAM 2019.”, Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Silymarin-enriched extract from milk thistle activates thermogenesis in a preclinical model of high-fat-diet-induced obesity to relieve systemic meta-inflammation

  • Reguero, Marina
  • Reglero, Guillermo
  • Quintela, José Carlos
  • Ramos-Ruiz, Ricardo
  • Ramírez de Molina, Ana
  • Gómez de Cedrón, Marta
This article belongs to the Section Phytochemicals and Human Health., [Background]: Obesity and aging are associated with the progressive loss of brown adipose tissue (BAT), an increase in visceral white adipose tissue (vWAT), and a reduction in subcutaneous white adipose tissue (sWAT). The progressive expansion of visceral obesity promotes a low grade of systemic chronic inflammation (meta-inflammation), contributing to the onset of comorbidities such as type 2 diabetes mellitus (T2DM), metabolic syndrome, and even cancer. Thus, preserving the thermogenic activity of adipose tissue and improving the metabolic flexibility of sWAT could be an effective strategy to prevent the development of metabolic chronic diseases and promote healthy aging. Precision nutrition has emerged as a complementary approach to control the metabolic alterations associated with unhealthy obesity and aging. In a previous work, we described that a silymarin-enriched extract from milk thistle (Mthistle) increased markers of browning and thermogenesis in vitro in human differentiated adipocytes (SGBS)., [Objectives/methods]: Therefore, this study aims to evaluate the potential of Mthistle to activate thermogenesis in a preclinical model of high-fat diet (HFD)-induced obesity (DIO)., [Results]: Our results demonstrate that Mthistle increases systemic energy expenditure (EE), preserves body temperature after cold exposure, improves insulin resistance, and reduces inflammatory markers in WAT., [Conclusions]: Based on these results, silymarin-enriched extract from Mthistle may be proposed as a nutraceutical for the management of metabolic chronic diseases and/or accelerated aging., Funding was obtained by the Regional Government of Community of Madrid (NutriSION-CM Y2020/BIO-6350, P2018/BAA-4343-ALIBIRD2020-CM); Ministerio de Ciencia e Innovacion, Spain MCIN/AEI/10.13039/501100011033 (PID2019-110183RB-C21; PID2022-138295OB-I00); The European Regional Development Fund European Union “ERDF A way of making Europe”. Ramon Areces Foundation (CIVP19A5937); and the REACT EU Program FACINGLCOVID-CM (PD2022-004-REACT-EU) Marina Reguero obtained a predoctoral grant from the industrial predoctoral program of the Community of Madrid (IND2017/BIO-7826)., Peer reviewed
DIGITAL.CSIC. Repositorio Institucional del CSIC
Publicación Artículo científico (JournalArticle)

Randomized clinical trial in cancer patients shows immune metabolic effects exerted by formulated bioactive phenolic diterpenes with potential clinical benefits

  • Gómez de Cedrón, Marta
  • Moreno-Rubio, Juan
  • O Pascual, Victor de la
  • Alvarez, Beatriz
  • Villarino Sanz, Marta
  • Sereno, María
  • Gómez-Raposo, Cesar
  • Roa, Silvia
  • López Gómez, Miriam
  • Merino-Salvador, María
  • Jiménez-Gordo, Ana
  • Falagán Martínez, Sandra
  • Aguayo, Cristina
  • Zambrana, Francisco
  • Tabarés, Beatriz
  • Garrido-Rubiales, Beatriz
  • Cruz-Gil, Silvia
  • Fernández Díaz, Cristina M.
  • Fernández, Lara P.
  • Molina, Susana
  • Crespo, M. Carmen
  • Ouahid, Youness
  • Montoya, Juan Jose
  • Ramos-Ruiz, Ricardo
  • Reglero, Guillermo
  • Ramírez de Molina, Ana
  • Casado, Enrique
[Background]: Nutrients, including bioactive natural compounds, have been demonstrated to affect key metabolic processes implicated in tumor growth and progression, both in preclinical and clinical trials. Although the application of precision nutrition as a complementary approach to improve cancer treatments is still incipient in clinical practice, the development of powerful “omics” techniques has opened new possibilities for delivering nutritional advice to cancer patients. Precision nutrition may contribute to improving the plasticity and function of antitumor immune responses., [Objectives]: Herein, we present the results of a randomized, prospective, longitudinal, double-blind, and parallel clinical trial (NCT05080920) in cancer patients to explore the immune-metabolic effects of a bioactive formula based on diterpenic phenols from rosemary, formulated with bioactive alkylglycerols (Lipchronic© WO/2017/187000). The trial involved cancer patients, including those with lung cancer (LC), colorectal cancer (CRC), and breast cancer (BC), undergoing chemotherapy, targeted biological therapy, and/or immunotherapy. The main readouts of the study were the analysis of Lip on systemic inflammation, hemogram profile, anthropometry, lipid and glucose profiles, and tolerability. Additionally, a deep immune phenotyping of peripheral blood mononuclear cells (PBMCs) was performed to identify the functional effects of Lip on key mediators of the immune system., [Results]: Lip was well tolerated. The lung cancer subgroup of patients showed a reduction in biomarkers of systemic inflammation, including the neutrophil-to-lymphocyte ratio (NLR). Furthermore, modulation of key players in the immune system associated with the experimental treatment Lip compared to the control placebo (Pla) treatment was revealed, with particularities among the distinct subgroups of patients. Our results encourage further research to apply molecular nutrition-based strategies as a complementary tool in the clinical management of cancer patients, particularly in the current era of novel immunotherapies., [Clinical trial registration]: ClinicalTrials.gov, identifier NCT05080920, Funding was obtained by the Regional Government of Community of Madrid (P2018/BAA-4343-ALIBIRD2020-CM and NutriSION-CM Y2020/BIO-6350), Ministerio de Ciencia e Innovacion, Spain MCIN/AEI/10.13039/501100011033 (PID2019-110183RB-C21; PID2022-138295OB-I00), and by “ERDF A way of making Europe”, Ramon Areces Foundation (CIVP19A5937), and REACT EU Program FACINGLCOVID-CM (PD2022-004-REACT-EU) Comunidad de Madrid and The European Regional Development Fund (ERDF) European Union. Flow Cytometry was conducted by Flow Cytometry Unit, CNIC., being the Cytometer part of the Grant EQC2018-005009-P funded by MCIN/AEI/10.13039/501100011033 and by “ERDF A way of making Europe”., Peer reviewed
Recercat. Dipósit de la Recerca de Catalunya
Publicación Artículo científico (JournalArticle)

Fatty acids homeostasis during fasting predicts protection from chemotherapy toxicity

  • Barradas, Marta
  • Lázaro, Iolanda
  • Pozo Mendoza, Óscar J., 1975-
  • Sala Vila, Aleix
  • Fernandez-Marcos, Pablo J.
Fasting exerts beneficial effects in mice and humans, including protection from chemotherapy toxicity. To explore the involved mechanisms, we collect blood from humans and mice before and after 36 or 24 hours of fasting, respectively, and measure lipid composition of erythrocyte membranes, circulating micro RNAs (miRNAs), and RNA expression at peripheral blood mononuclear cells (PBMCs). Fasting coordinately affects the proportion of polyunsaturated versus saturated and monounsaturated fatty acids at the erythrocyte membrane; and reduces the expression of insulin signaling-related genes in PBMCs. When fasted for 24 hours before and 24 hours after administration of oxaliplatin or doxorubicin, mice show a strong protection from toxicity in several tissues. Erythrocyte membrane lipids and PBMC gene expression define two separate groups of individuals that accurately predict a differential protection from chemotherapy toxicity, with important clinical implications. Our results reveal a mechanism of fasting associated with lipid homeostasis, and provide biomarkers of fasting to predict fasting-mediated protection from chemotherapy toxicity., Work at the laboratory of P.J.F.M. is funded by the Ramón Areces Foundation, (CIVP18A3891), Asociación Española contra el Cáncer-AECC (SIRTBIO—LABAE18008FERN), a Ramon y Cajal Award from the Spanish Ministry of Science, Innovation and Universities (MICINN) (RYC-2017-22335), RETOS projects Program of MICINN (SAF2017-85766-R) and the Portuguese Foundation for Science and Technology (FCT-MCTES, SFRH/BD/124022/2016). Work at the laboratory of ARM was funded by the MICINN (PID2019-110183RB-C21), Regional Government of Community of Madrid (P2018/BAA-4343-ALIBIRD2020-CM) and the Ramón Areces Foundation. Work at the laboratory of A.D.R. Funded by the Comunidad de Madrid—Talento Grant 2018-T1/BMD-11966 and the MICINN PID-2019-106893RA-100. Work at the laboratory of L.D. is funded by projects from the Health Research Fund (ISCIII FIS PI14/01374 and FISPI17/00508) and from a Manuel de Oya research fellowship from the Beer and Health Foundation. Work at the laboratory of A.E. is funded by a Ramon y Cajal Award from MICINN (RYC-2013-13546) and RETOS projects Program of the MICINN, co-funded by the European Regional Development Fund (ERDF) (SAF2015-67538-R). Work in the laboratory of M.S. was funded by the IRB and by grants from the Spanish Ministry of Economy co-funded by the European Regional Development Fund (ERDF) (SAF2013-48256-R), the European Research Council (ERC-2014-AdG/669622), and the “laCaixa” Foundation.
Docta Complutense
Publicación Artículo científico (JournalArticle)

Sweet Taste Receptors’ Genetic Variability in Advanced Potential Targets of Obesity

  • Loria Kohen, Viviana Constanza
  • Wagner Reguero, Sonia
  • Fernández, Lara P.
  • Colmenarejo, Gonzalo
  • Cruz-Gil, Silvia
  • Espinosa, Isabel
  • Molina, Susana
  • Crespo, María Carmen
  • Aguilar-Aguilar, Elena
  • Marcos-Pasero, Helena
  • de la Iglesia, Rocío
  • Ramos Ruiz, Ricardo
  • Laparra-Llopis, Moisés
  • Ramírez de Molina, Ana
  • Gómez de Cedrón, Marta
Background: Obesity, mainly visceral obesity, causes a low-grade of chronic inflammation (meta-inflammation), associated with comorbidities such as type 2 diabetes, cardiovascular diseases, and certain cancers. Precision Nutrition aims to understand the bidirectional crosstalk between the genome and diet to improve human health. Additionally, by leveraging individual data, Precision Nutrition seeks to predict how people will respond to specific foods or dietary patterns, with the ultimate goal of providing personalized nutritional recommendations tailored to their unique needs and lifestyle factors, including poor dietary habits (e.g., high intake of sugar or saturated fatty acids, alcohol consumption, etc.) and sedentary habits, exacerbate obesity in genetically predisposed individuals. Genetic, metabolic, and environmental factors can play a crucial role during obesity. Objective: To investigate the effects of genetic variability in sweet taste receptors and their downstream signaling pathways in the gut–brain axis on anthropometry, biochemistry, and lifestyle variables. Methods: A sample of 676 volunteers (mean age of 42.22 ± 12 years, ranging from 18 to 73 years) from the database of the GENYAL platform for nutritional trials at the IMDEA Food Institute were included in this study. We present a first-in-class genetic chip, Glucosensing, designed to interrogate 25 single-nucleotide polymorphisms (SNPs) located in genes encoding sweet taste receptors and components of downstream signaling pathways. These include elements of the gut–brain axis and its associated metabolic networks, enabling a comprehensive analysis of individual variability in sweet taste perception and metabolic responses. Results: Several significant associations were found after correction for multiple comparisons, representing potential targets for personalized interventions.